Bone
tissue engineering aims to regenerate defected bones by combining
cells, scaffolds, and growth factors. In general, defected bone tissues
are treated with barrier membranes or guiding scaffolds to achieve
bone restoration. However, the growth rate of bone tissue is slower
than that of adjacent soft tissue. Therefore, we propose patient-customizable
guided bone regeneration (GBR) and membrane-guided tissue regeneration
(GTR) scaffold hybrid constructs for precise bone tissue restoration
without dimensional collapse beyond the critical bone defect size.
Silk fibroin (SF) nanofiber membranes and poly(glycolic acid) (PGA)
scaffolds were fabricated using electrospinning and hot-melt additive
manufacturing methods based on a computer-generated scaffold design.
Their manipulation parameters, microstructures, compressive moduli,
and biodegradability were investigated. The initial attachment and
proliferation of preosteoblasts on a PGA scaffold were analyzed based
on seeding efficiency and a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide assay. The regenerated bone volumes of control and SF–PGA
hybrid scaffolds were 14.8 and 21.4%, respectively, after 8 weeks
of in vivo rabbit calvarial defect regeneration. The SF–PGA
hybrid scaffold group exhibits greater regeneration of bone tissue
than the control and PGA scaffold groups, indicating that this is
a promising material combination as a GBR–GTR agent.
Porous collagen scaffolds with micropatterned structures are manufactured using preformed ice micropattern templates. The scaffolds show precisely controlled pore structures and micropattern structures of bioactive substances, which can be tethered by designing a program.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.